For help on how to get the results you want, see our search tips.
1858 results
Categories
Human Remove Human filter
Medicine
Orphan designations Remove Orphan designations filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Orphan designation status
Positive Remove Positive filter
-
List item
Orphan designation: Heterologous human adult liver-derived progenitor cells for: Treatment of argininosuccinic aciduria
Date of designation: 17/07/2013, Positive, -
List item
Orphan designation: Masitinib mesilate for: Treatment of pancreatic cancer
Date of designation: 28/10/2009, Positive, -
List item
Orphan designation: 2',3',5'-Tri-O-acetyluridine for: Treatment of 5-fluorouracil overdose
Date of designation: 15/05/2009, Positive, Last updated: 09/06/2009 -
List item
Orphan designation: 2-[4-Methoxy-3-(2-m-tolyl-ethoxy)-benzoylamino]-indan-2-carboxylic acid for: Treatment of systemic sclerosis
Date of designation: 12/03/2013, Positive, Last updated: 18/09/2020 -
List item
Orphan designation: Eflornithine for: Treatment of familial adenomatous polyposis (FAP)
Date of designation: 20/09/2010, Positive, Last updated: 29/04/2019 -
List item
Orphan designation: Propranolol for: Treatment of soft tissue sarcoma
Date of designation: 12/12/2016, Positive, -
List item
Orphan designation: Mixture of two adeno-associated viral vectors serotype 8 containing the 5'-half sequence of human MYO7A gene and the 3'-half sequence of human MYO7A gene for: Treatment of Usher syndrome
Date of designation: 04/07/2014, Positive, -
List item
Orphan designation: Repertaxin L-lysine salt for: Prevention of delayed graft function in organ transplant
Date of designation: 19/09/2001, Positive, -
List item
Orphan designation: Ursodeoxycholic acid for: Treatment of Niemann-Pick disease
Date of designation: 22/05/2017, Positive, Last updated: 25/04/2019 -
List item
Orphan designation: Pyridoxal 5'-phosphate for: Treatment of pyridoxamine 5'-phosphate oxidase deficiency
Date of designation: 15/10/2014, Positive, -
List item
Orphan designation: Recombinant human histone H1.3 and recombinant human N-bis-met-histone H1.3 for: Treatment of acute myeloid leukaemia
Date of designation: 20/12/2007, Positive, Last updated: 13/03/2013 -
List item
Orphan designation: Methylthioninium for: treatment of frontotemporal dementia with parkinsonism-17
Date of designation: 26/11/2010, Positive, Last updated: 28/03/2019 -
List item
Orphan designation: Poly-cyclodextrin-bis-cysteine-PEG3400-camptothecin-conjugate for: Treatment of ovarian cancer
Date of designation: 20/03/2017, Positive, Last updated: 05/05/2017 -
List item
Orphan designation: Human MHC non-restricted cytotoxic T-cell line for: Treatment of ovarian cancer
Date of designation: 30/11/2009, Positive, -
List item
Orphan designation: afamelanotide for: Treatment of solar urticaria
Date of designation: 24/07/2009, Positive, Last updated: 11/04/2016 -
List item
Orphan designation: Adenovirus associated viral vector serotype 4 containing the human RPE65 gene for: Treatment of Leber's congenital amaurosis
Date of designation: 22/10/2007, Positive, -
List item
Orphan designation: Nitric oxide for: Treatment of cystic fibrosis
Date of designation: 15/10/2014, Positive, -
List item
Orphan designation: 68Ga-DOTA-pABzA-DIG-dPhe-Gln-Trp-Ala-Val-Gly-His-NHCH[(CH2-CH(CH3)2]2 for: Diagnosis of gastrointestinal stromal tumours
Date of designation: 12/12/2016, Positive, -
List item
Orphan designation: N'-(5-chloro-2-hydroxy-3-methylbenzylidene)-2,4-dihydroxybenzhydrazide for: Treatment of partial deep dermal and full-thickness burns
Date of designation: 22/09/2008, Positive, Last updated: 06/04/2011 -
List item
Orphan designation: Veliparib for: Treatment of ovarian cancer
Date of designation: 17/12/2010, Positive, Last updated: 29/05/2018 -
List item
Orphan designation: Volasertib for: Treatment of acute myeloid leukaemia
Date of designation: 26/03/2014, Positive, -
List item
Orphan designation: 5,6,7,8-Tetrahydrobiopterin for: Treatment of hyperphenylalaninaemia
Date of designation: 02/10/2003, Positive, Last updated: 23/02/2007 -
List item
Orphan designation: Caffeine citrate for: Prevention of bronchopulmonary dysplasia
Date of designation: 11/04/2014, Positive, -
List item
Orphan designation: Volanesorsen sodium for: Treatment of familial partial lipodystrophy
Date of designation: 14/07/2016, Positive, Last updated: 23/05/2019 -
List item
Orphan designation: Methotrexate for: Treatment of alkaptonuria
Date of designation: 29/08/2016, Positive,